Design of iron chelators with therapeutic application
The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Abstract
Iron is essential for the proper functioning of all living cells, however it is toxic when present in excess. Thus, using iron chelators as therapeutic agents, namely chelation therapy, has received increasing attention. The objective of this review is to discuss the factors which should be considered when designing clinically useful iron chelators, to present the application of iron chelators in the treatment of iron overload associated with β-thalassaemia major and sickle cell anaemia, and to highlight the potential applications in the treatment of neurodegenerative disorders and microbial infection. This article reviews recent knowledge centred on these themes and indicates the growing importance of the concept of iron chelation in medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An effective iron chelator must be nontoxic, must have higher affinity for ferric iron than bacterial siderophores and must not be recognized by microbial siderophore transporters94.”
From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [94]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Chemistry and biology of siderophores
Hider, R. C., & Kong, X. (2010) · Natural Product Reports · doi:10.1039/b906679a · Cited by 1,722
Self-citationRae, T. D., Schmidt, P. J., Pufahl, R. A., Culotta, V. C., & V. O'Halloran, T. (1999) · Science · doi:10.1126/science.284.5415.805 · Cited by 1,629
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315
Weinberg, E. D. (1978) · Microbiological Reviews · doi:10.1128/mmbr.42.1.45-66.1978 · Cited by 1,254
Protective effects of the sickle cell gene against malaria morbidity and mortality
Aidoo, M., Terlouw, D. J., Kolczak, M. S., McElroy, P. D., ter Kuile, F. O., Kariuki, S., Nahlen, B. L., Lal, A. A., & Udhayakumar, V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08273-9 · Cited by 700
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Pardridge, W. M., Boado, R. J., & Farrell, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38267-x · Cited by 606
Rational Design of Sequestering Agents for Plutonium and Other Actinides
Gorden, A. E. V., Xu, J., Raymond, K. N., & Durbin, P. (2003) · Chemical Reviews · doi:10.1021/cr990114x · Cited by 552
Research works printed but not linked: 11
- Pearson, 1963, J. Am. Chem. Soc., 85, 3535
- Thieken, 1992, FEMS Microbiol. Lett., 94, 37, 10.1111/j.1574-6968.1992.tb05285.x · doi:10.1111/j.1574-6968.1992.tb05285.x · Paper page
- Holander, 1988, Can. J. Gastroenterol., 2, 35A
- Hider, 1992, Proc. R. Soc. Edinburgh, 99B, 137
- Hershko, 1978, J. Lab. Clin. Med., 92, 144
- Pippard, 1978, Clin. Sci. Mol. Med., 54, 99
- Wolfe, 1990, Semin. Hematol., 27, 117
- Galanello, 2003, J. Clin. Pharmacol., 43, 565, 10.1177/0091270003253350 · doi:10.1177/0091270003253350 · Paper page
- Piga, 2003, J. Hematol., 88, 489
- Oakley, 1973, JAMA, J. Am. Med. Assoc., 225, 395, 10.1001/jama.1973.03220310031006 · doi:10.1001/jama.1973.03220310031006
- Albert, 1947, Br. J. Exp. Path., 28, 69
Cited by
Nutritional immunity: transition metals at the pathogen–host interface
Hood, M. I., & Skaar, E. P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2836 · Cited by 1,535
Iron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Jack of all trades: versatile catechol crosslinking mechanisms
Yang, J., Cohen Stuart, M. A., & Kamperman, M. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00185k · Cited by 702
Singh, N., Haldar, S., Tripathi, A. K., Horback, K., Wong, J., Sharma, D., Beserra, A., Suda, S., Anbalagan, C., Dev, S., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4931 · Cited by 208
Metadata
- Authors
- Zhou, T., Ma, Y., Kong, X., & Hider, R. C.
- Affiliations
- Zhejiang Gongshang University (CN)
- King's College London (GB)
- Corresponding author
- Hider, Robert C.
- Venue
- Dalton Transactions
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2012
- Volume
- 41
- Issue
- 21
- Pages
- 6371
- ISSN
- 1477-9226 (ISSN-L)
- 1477-9234
- OpenAlex
- W2028066320
- Cited by
- 136
- References
- 142
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 10 · 2018: 14 · 2017: 13 · 2016: 7 · 2015: 12 · 2014: 11 · 2013: 15 · 2012: 5
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Dalton Transactions (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- iron chelators, chelation therapy, iron overload, beta-thalassaemia major, sickle cell disease, neurodegenerative diseases, microbial infection, drug design, iron toxicity
- MeSH terms
- Anti-Bacterial Agents, Humans, Iron Chelating Agents, Drug Design, Iron Overload
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design of iron chelators with therapeutic application. https://app.cochat.ai/papers/10.1039/c2dt12159j
- The paper
- Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012). Design of iron chelators with therapeutic application. Dalton Transactions. https://doi.org/10.1039/c2dt12159j
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.